Article
Airway gene expression identifies subtypes of type 2 inflammation in severe asthma
18 Jun 2021
Abstract excerpt
BACKGROUND: Type 2 inflammation is characterized by enhanced activity of interleukin (IL)-4, -5 and -13, and treatments targeting these pathways are available for treatment of severe asthma. At present, the pattern of pathway activity and the implications overlapping of pathway activity are unknown. OBJECTIVE: We hypothesized that clustering of airway mRNA expression would identify distinct molecular subtypes of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
